For sales

📢Highlights from the Week of October 13 – 20, 2025 in the world of pharma and healthcare! 🗞️👀

Vyuhpharma Highlights from the Week of October 13-20, 2025 AbbVie (FDA, Drug Approval) FDA approves revised indication for Abbvie's RINVOQ® (upadacitinib) to treat inflammatory bowel disease Roche (FDA, Approval) FDA approves Roche's Elecsys® pTau181 as the exclusive blood test for primary care to rule out Alzheimer's-related amyloid pathology Roche (FDA, Approval) Roche's Gazyva/Gazyvaro receives FDA approval for lupus nephritis treatment Novo Nordisk (FDA, Approval) FDA has approved Novo Nordisk's oral semaglutide to lower heart disease risk in high-risk adults with type 2 diabetes, even if they have not had a heart attack or stroke before All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.